What is NMTC's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for NMTC?

P/E (TTM) is n/a and 52-week range is $0.96 to $6.42 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s NMTC figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for NMTC?

The company profile lists revenue (TTM) near $10M, net income (TTM) near $-718M, EPS (TTM) near $-0.84 when available from the market-data feed. Figures are informational and may lag live markets.

Where is NeuroOne Medical Technologies Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Eden Prairie, Minnesota, US, 8.7M shares outstanding, ISIN US64130M3088 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

NeuroOne Medical Technologies Corp

$NMTC

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.10

+2.33%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

NeuroOne Medical Technologies Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Eden Prairie, Minnesota and currently employs 18 full-time employees. The company went IPO on 2012-11-09. NeuroOne Medical Technologies Corporation is a medical technology company. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Employees

Website

nmtc1.com/

IPO

2012-11-09

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)